Author(s): Keller RJ, Eisenbarth GS, Jackson RA
Abstract Share this page
Abstract Prevention of type I diabetes is now a practical goal thanks to the ability to define confidently a high-risk group and the success of preventive strategies in animal models. We describe here a pilot trial of low-dose insulin to prevent diabetes in relatives of patients with type I diabetes.
This article was published in Lancet
and referenced in Journal of Clinical & Cellular Immunology